Fungal Skin Disease Incidence, Prevalence and Disability-Adjusted Life Years in Four Asian Countries (1990-2019)
- PMID: 39888053
- DOI: 10.1111/myc.70004
Fungal Skin Disease Incidence, Prevalence and Disability-Adjusted Life Years in Four Asian Countries (1990-2019)
Abstract
Background: Fungal skin diseases are a significant burden in Asia, with varying trends from 1990 to 2019, highlighting the need for targeted interventions.
Objective: To investigate long-term trends in the incidence, prevalence and disability-adjusted life-year rates for fungal skin diseases in China, India, Japan and Singapore from 1990 to 2019.
Patients/methods: Data were obtained from the 2019 Global Burden of Disease Study. Independent age, period and cohort effects were calculated using age-period-cohort analysis.
Results: Age-standardised incidence, prevalence and disability-adjusted life-year rates of fungal skin diseases in China, India, Japan and Singapore decreased from 1990 to 2019. India has the highest standardised incidence, prevalence and disability-adjusted life-year rates. The crude incidence, prevalence and disability-adjusted life-year rates showed an increasing trend in China, Japan and Singapore, and a decreasing trend in India. The age-period-cohort analysis found that the age effect increased in China, Japan and Singapore at ages 45-94 years, and India showed higher risk coefficients at ages 5-20 and 45-94 years. The period effect increased in the four countries, with more pronounced increases in Japan and Singapore. The cohort effect showed a monotonic decline with birth cohort in the four countries, with a slightly slower decline in India.
Conclusion: Fungal skin diseases pose a serious burden in Asian countries. We recommend raising awareness and providing specialised interventions for fungal skin diseases, especially for high-risk groups, such as middle-aged and older adults aged ≤ 45 years and young Indians aged ≤ 20 years.
Keywords: age–period–cohort analysis; disability‐adjusted life years; fungal skin diseases; incidence; prevalence.
© 2025 Wiley‐VCH GmbH. Published by John Wiley & Sons Ltd.
References
-
- F. Bongomin, S. Gago, R. O. Oladele, and D. W. Denning, “Global and Multi‐National Prevalence of Fungal Diseases‐Estimate Precision,” Journal of Fungi 3 (2017): 57, https://doi.org/10.3390/jof3040057.
-
- GBD 2016 Disease and Injury Incidence and Prevalence Collaborators, “Global, Regional, and National Incidence, Prevalence, and Years Lived With Disability for 328 Diseases and Injuries for 195 Countries, 1990–2016: A Systematic Analysis for the Global Burden of Disease Study 2016,” Lancet 390 (2017): 1211–1259, https://doi.org/10.1016/s0140‐6736(17)32154‐2.
-
- B. Havlickova, V. A. Czaika, and M. Friedrich, “Epidemiological Trends in Skin Mycoses Worldwide,” Mycoses 51, no. Suppl 4 (2008): 2–15, https://doi.org/10.1111/j.1439‐0507.2008.01606.x.
-
- M. Ameen, “Epidemiology of Superficial Fungal Infections,” Clinics in Dermatology 28 (2010): 197–201, https://doi.org/10.1016/j.clindermatol.2009.12.005.
-
- Y. Zhao, Q. Qiao, X. Xu, and Y. Bian, “Effectiveness of Hierarchical Medical System and Economic Growth: Based on China's Urban Versus Rural Health Perspectives,” Frontiers in Public Health 12 (2024): 1364584.
MeSH terms
LinkOut - more resources
Full Text Sources